EGFR and cancer: To investigate possible crosstalk of integrin β4 with the EGFR in the promotion of cancer signaling, we first characterized EGFR-mediated β4 tyrosine phosphorylation in multiple benign and malignant epithelial cell lines derived from breast, colon and skin tissues.